Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genomic Profiling of Sarcomas: A Promising Weapon in the Therapeutic Arsenal

17 Nov 2022

Abstract excerpt

Sarcomas are rare malignant mesenchymal neoplasms, and the knowledge of tumor biology and genomics is scarce. Chemotherapy is the standard of care in advanced disease, with poor outcomes. Identifying actionable genomic alterations may offer effective salvage therapeutic options when previous lines have failed. Here, we report a retrospective cohort study of sarcoma patients followed at our center and submitted to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CAR-T cell therapy research
Share to Sarcoma Diagnosis and Treatment
Share to Virus-based gene therapy research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36430703
DOI: 10.3390/ijms232214227

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genomic Profiling of Sarcomas: A Promising Weapon in the Therapeutic ArsenalPMID 36430703Read ↗

The Landscape of Alterations from 1407 Ultra-Rare Sarcomas from the AACR GENIE Database: Clinical Implications.Semantic proximity Read ↗

Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma.Semantic proximity Read ↗

Precision Oncology in Sarcomas: Divide and ConquerSemantic proximity Read ↗

Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targetsSemantic proximity Read ↗

Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targetsSemantic proximity Read ↗

Implementing precision oncology for sarcoma patients: the CCCLMUmolecular tumor board experience.Semantic proximity Read ↗

The clinical utility of next-generation sequencing for bone and soft tissue sarcoma.Semantic proximity Read ↗

Real-World Implementation of Next-Generation Sequencing in Sarcoma: Molecular Insights and Therapeutic Outcomes.Semantic proximity Read ↗

Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas.Semantic proximity Read ↗

A clinico-genomic analysis of soft tissue sarcoma patients reveals CDKN2A deletion as a biomarker for poor prognosisSemantic proximity Read ↗

Targetable Alterations in Adult Patients With Soft-Tissue SarcomasSemantic proximity Read ↗

Clinical genomic profiling to identify actionable alterations for investigational therapies in patients with diverse sarcomas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.